PMID: 7536294Jun 1, 1995Paper

Combination chemotherapy with vinblastine, bleomycin, cisplatin, and etoposide (VBPE) in children with primary intracranial germ cell tumors

Medical and Pediatric Oncology
T K ChangB Hwang

Abstract

We have treated 13 children with primary intracranial germ cell tumors with the combination of vinblastine, bleomycin, cisplatin, and etoposide, the so-called VBPE regimen in the past seven years at one institution. The clinical diagnosis of these children were: three germinomas, seven non-germinomatous germ cell tumors, and three recurrent non-germinomatous germ cell tumors without previous chemotherapy. Of this group, three germinomas and three non-germinomatous germ cell tumors were treated primarily with VBPE plus radiotherapy. All of them responded completely, and were free of tumor. Primary VBPE regimen without radiotherapy was used in another four non-germinomatous germ cell tumors. After six courses of VBPE regimen, only one of the four patients achieved complete response for 30 months. VBPE regimen was used as salvage chemotherapy in three recurrent non-germinomatous germ cell tumors without previous chemotherapy. After six courses of VBPE regimen, two had complete response for 58+ months and 78+ months respectively. We concluded that in newly-diagnosed intracranial non-germinomatous germ cell tumors, the combination of chemotherapy VBPE regimen and radiotherapy led to good results. Primary chemotherapy with VBPE alone...Continue Reading

References

Nov 1, 1979·Journal of Neurosurgery·E A NeuweltW K Clark
Jan 1, 1978·Journal of Neurosurgery·R D JenkinC W Keen
Jan 1, 1990·Medical and Pediatric Oncology·V L CastañedaA E Marlin
Apr 1, 1991·Journal of Neurosurgery·H J HoffmanD Jenkin
Apr 1, 1990·International Journal of Radiation Oncology, Biology, Physics·D P DearnaleyH J Bloom
Jan 1, 1987·Progress in Experimental Tumor Research·M MatsutaniK Sano
Aug 1, 1985·Journal of Neurosurgery·M T JenningsF Hochberg
Aug 1, 1988·International Journal of Radiation Oncology, Biology, Physics·D LinstadtG E Sheline

❮ Previous
Next ❯

Citations

Oct 31, 2003·Current Treatment Options in Oncology·Hanspreet KaurDavid M Peereboom
Oct 1, 1996·International Journal of Radiation Oncology, Biology, Physics·S E SchildP J Schomberg
Jun 12, 2002·Pediatric Neurology·Tang-Her JaingTai-Ngar Lui
Feb 20, 2010·Neuro-oncology·J Lee VillanoBridget J McCarthy
Aug 25, 2015·Journal of the Chinese Medical Association : JCMA·Lu-Jen ChenYi-Wei Chen
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stewart J KellieJonathan L Finlay
Feb 16, 2019·Pediatric Blood & Cancer·Mohammad H Abu ArjaMohamed S AbdelBaki
Nov 3, 2010·Current Opinion in Neurology·Girish DhallJonathan L Finlay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
H L Weiner, Jonathan L Finlay
© 2021 Meta ULC. All rights reserved